| Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes MM Hosseini, SE Kurtz, S Abdelhamed, S Mahmood, MA Davare, ... Leukemia 32 (11), 2374-2387, 2018 | 64 | 2018 |
| Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells J McClatchy, R Strogantsev, E Wolfe, HY Lin, M Mohammadhosseini, ... Nature communications 14 (1), 8102, 2023 | 12 | 2023 |
| Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia RV Modak, KG de Oliveira Rebola, J McClatchy, M Mohammadhosseini, ... Clinical Cancer Research 30 (10), 2245-2259, 2024 | 3 | 2024 |
| The TLK-ASF1 histone chaperone pathway plays a critical role in IL-1β-mediated AML progression HY Lin, M Mohammadhosseini, J McClatchy, M Villamor-Payà, S Jeng, ... Blood, 2024 | 2 | 2024 |
| Runx1-R188Q germ line mutation induces inflammation and predisposition to hematologic malignancies in mice MH Ahmad, M Hegde, WJ Wong, M Mohammadhosseini, L Garrett, ... Blood Advances 7 (23), 7304-7318, 2023 | 2 | 2023 |
| The transcriptional and epigenetic reprogramming mediated by chronic IL1β exposure drives self-renewal ability and myeloid priming in TET2 deficient stem and progenitor cells J McClatchy, R Strogantsev, E Wolfe, J Estabrook, H Lin, ... Cancer Biol 10 (2022.09), 15.507688, 2022 | 1 | 2022 |
| Marcks is a critical downstream mediator of IL-1-Driven AML progression MM Hosseini, HY Lin, G Dewson, R Vivier, A Agarwal Blood 134, 2679, 2019 | 1 | 2019 |
| Interplay between Inflammatory Microenvironment and RUNX1-Mediated Transcriptomic Changes Drives Defective Hematopoiesis in Familial Platelet Disorder M M Hosseini, T Enright, AS Duvall, A Chitsazan, HY Lin, A Ors, B Davis, ... Blood 142 (Supplement 1), 945-945, 2023 | | 2023 |
| Chronic IL1β Exposure Enhances Self-Renewal Ability and Myeloid Priming in TET2 Deficient Stem and Progenitor Cells J McClatchy, R Strongantsev, E Wolfe, J Estabrook, HY Lin, M M Hosseini, ... Blood 140 (Supplement 1), 8594-8595, 2022 | | 2022 |
| The transcriptional and epigenetic reprogramming associated with chronic IL1β-mediated expansion and myeloid priming in TET2 deficient stem and progenitor cells J McClatchy, R Strogantsev, E Wolfe, H Lin, M Mohammadhosseini, ... bioRxiv, 2022.09. 15.507688, 2022 | | 2022 |
| 3024–GERMLINE RUNX1 MUTATIONS-MEDIATED CHANGES COOPERATES WITH INFLAMMATORY MICROENVIRONMENT TO DRIVE DEFECTIVE HEMATOPOIESIS IN FAMILIAL PLATELET DISORDER M Mohammadhosseini, A Duvall, A Chitsazan, T Enright, A Monteblanco, ... Experimental Hematology 100, S55, 2021 | | 2021 |
| Disruption of a histone chaperone pathway delays inflammation-driven AML progression HY Lin, M Mohammadhosseini, M Villamor, J McClatchy, S Jeng, A Adey, ... Cancer Research 81 (13_Supplement), 531-531, 2021 | | 2021 |
| 3021–A NOVEL HISTONE CHAPERONE PATHWAY DRIVES IL-1β-MEDIATED AML PROGRESSION HY Lin, M Mohammadhosseini, M Villamor, A Adey, S McWeeney, ... Experimental Hematology 88, S44, 2020 | | 2020 |
